Lemaitre Vascular (LMAT) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
LeMaitre Vascular (LMAT) PT Raised to $40 at Stifel
February 22, 2018 12:01 PM ESTStifel raised its price target on LeMaitre Vascular (NASDAQ: LMAT) to $40.00 (from $35.00) while maintaining a Buy rating following results.
Analyst Rick Wise said they would prefer to accumulate the stock on share price pullbacks/weakness for investors with a longer-term point of view.
... More